Andrew Fein
Stock Analyst at HC Wainwright & Co.
(2.24)
# 2,460
Out of 4,814 analysts
596
Total ratings
36.23%
Success rate
-3.95%
Average return
Main Sectors:
Stocks Rated by Andrew Fein
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ARVN Arvinas | Reiterates: Buy | $81 | $8.75 | +825.71% | 18 | Apr 7, 2025 | |
| IMAB I-Mab | Maintains: Buy | $8 → $7 | $0.86 | +718.71% | 13 | Apr 4, 2025 | |
| ACIU AC Immune | Reiterates: Buy | $16 | $1.48 | +981.08% | 15 | Apr 3, 2025 | |
| KROS Keros Therapeutics | Reiterates: Buy | $40 | $14.30 | +179.72% | 14 | Apr 1, 2025 | |
| PVLA Palvella Therapeutics | Reiterates: Buy | $38 | $25.45 | +49.31% | 5 | Apr 1, 2025 | |
| ABOS Acumen Pharmaceuticals | Maintains: Buy | $15 → $11 | $1.06 | +937.74% | 11 | Mar 28, 2025 | |
| SVRA Savara | Reiterates: Buy | $6 | $3.05 | +96.72% | 12 | Mar 28, 2025 | |
| ZNTL Zentalis Pharmaceuticals | Reiterates: Buy | $10 | $1.37 | +629.93% | 18 | Mar 27, 2025 | |
| WVE Wave Life Sciences | Reiterates: Buy | $22 | $6.12 | +259.48% | 12 | Mar 26, 2025 | |
| LQDA Liquidia | Reiterates: Buy | $29 | $13.29 | +118.21% | 12 | Mar 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $47 | $8.61 | +445.88% | 13 | Mar 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $72 | $28.60 | +151.75% | 4 | Mar 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $46 | $9.33 | +393.03% | 11 | Mar 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $12 → $2 | $0.55 | +262.12% | 16 | Mar 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $17 → $14 | $1.71 | +718.71% | 13 | Mar 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $20 | $12.07 | +65.70% | 14 | Mar 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 → $12 | $1.32 | +809.09% | 12 | Mar 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $13 | $3.93 | +230.79% | 14 | Mar 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $11 | $6.40 | +71.88% | 10 | Mar 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $23 | $3.85 | +497.40% | 14 | Mar 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $15 | $1.53 | +880.39% | 13 | Mar 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $8 | $2.51 | +218.73% | 1 | Mar 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $12 | $4.23 | +183.69% | 19 | Mar 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $85 | $43.26 | +96.49% | 16 | Mar 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $35 | $22.02 | +58.95% | 14 | Feb 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $54 → $60 | $27.13 | +121.20% | 7 | Feb 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $80 → $87 | $13.16 | +561.09% | 21 | Feb 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $27 | $14.38 | +87.76% | 18 | Feb 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $425 | $284.25 | +49.52% | 14 | Feb 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $7 | $0.98 | +613.92% | 9 | Feb 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | $4 | $3.53 | +13.31% | 17 | Feb 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $30 | $7.53 | +298.41% | 9 | Feb 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $16 | $1.52 | +952.63% | 11 | Feb 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $48 | $9.31 | +415.85% | 16 | Feb 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $185 | $100.68 | +83.75% | 19 | Feb 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $90 | $69.51 | +29.48% | 13 | Feb 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $75 | $6.30 | +1,090.48% | 7 | Feb 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $135 | $84.18 | +60.37% | 17 | Feb 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $300 → $241 | $116.49 | +106.88% | 19 | Feb 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $550 | $477.52 | +15.18% | 26 | Feb 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $75 | $20.41 | +267.47% | 1 | Jan 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $80 | $23.10 | +246.32% | 3 | Dec 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $30 | $1.68 | +1,685.71% | 14 | Dec 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $25 → $35 | $8.91 | +292.82% | 11 | Oct 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $8 | $0.92 | +769.47% | 7 | Aug 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $17 → $7 | $1.40 | +400.00% | 6 | Nov 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $6.16 | +62.34% | 5 | Aug 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $100 → $40 | $1.91 | +1,994.24% | 3 | Feb 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $150 | $0.60 | +25,110.08% | 1 | Jan 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $200 → $60 | $9.55 | +528.27% | 4 | May 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $15 | $2.24 | +569.64% | 1 | Apr 27, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $80 → $40 | $1.49 | +2,584.56% | 3 | Mar 16, 2022 |
Arvinas
Apr 7, 2025
Reiterates: Buy
Price Target: $81
Current: $8.75
Upside: +825.71%
I-Mab
Apr 4, 2025
Maintains: Buy
Price Target: $8 → $7
Current: $0.86
Upside: +718.71%
AC Immune
Apr 3, 2025
Reiterates: Buy
Price Target: $16
Current: $1.48
Upside: +981.08%
Keros Therapeutics
Apr 1, 2025
Reiterates: Buy
Price Target: $40
Current: $14.30
Upside: +179.72%
Palvella Therapeutics
Apr 1, 2025
Reiterates: Buy
Price Target: $38
Current: $25.45
Upside: +49.31%
Acumen Pharmaceuticals
Mar 28, 2025
Maintains: Buy
Price Target: $15 → $11
Current: $1.06
Upside: +937.74%
Savara
Mar 28, 2025
Reiterates: Buy
Price Target: $6
Current: $3.05
Upside: +96.72%
Zentalis Pharmaceuticals
Mar 27, 2025
Reiterates: Buy
Price Target: $10
Current: $1.37
Upside: +629.93%
Wave Life Sciences
Mar 26, 2025
Reiterates: Buy
Price Target: $22
Current: $6.12
Upside: +259.48%
Liquidia
Mar 20, 2025
Reiterates: Buy
Price Target: $29
Current: $13.29
Upside: +118.21%
Mar 19, 2025
Reiterates: Buy
Price Target: $47
Current: $8.61
Upside: +445.88%
Mar 18, 2025
Reiterates: Buy
Price Target: $72
Current: $28.60
Upside: +151.75%
Mar 17, 2025
Reiterates: Buy
Price Target: $46
Current: $9.33
Upside: +393.03%
Mar 17, 2025
Downgrades: Neutral
Price Target: $12 → $2
Current: $0.55
Upside: +262.12%
Mar 14, 2025
Maintains: Buy
Price Target: $17 → $14
Current: $1.71
Upside: +718.71%
Mar 14, 2025
Reiterates: Buy
Price Target: $20
Current: $12.07
Upside: +65.70%
Mar 14, 2025
Maintains: Buy
Price Target: $10 → $12
Current: $1.32
Upside: +809.09%
Mar 7, 2025
Reiterates: Buy
Price Target: $13
Current: $3.93
Upside: +230.79%
Mar 6, 2025
Reiterates: Buy
Price Target: $11
Current: $6.40
Upside: +71.88%
Mar 6, 2025
Reiterates: Buy
Price Target: $23
Current: $3.85
Upside: +497.40%
Mar 6, 2025
Reiterates: Buy
Price Target: $15
Current: $1.53
Upside: +880.39%
Mar 6, 2025
Initiates: Buy
Price Target: $8
Current: $2.51
Upside: +218.73%
Mar 5, 2025
Reiterates: Buy
Price Target: $12
Current: $4.23
Upside: +183.69%
Mar 3, 2025
Reiterates: Buy
Price Target: $85
Current: $43.26
Upside: +96.49%
Feb 28, 2025
Reiterates: Buy
Price Target: $35
Current: $22.02
Upside: +58.95%
Feb 28, 2025
Maintains: Buy
Price Target: $54 → $60
Current: $27.13
Upside: +121.20%
Feb 28, 2025
Maintains: Buy
Price Target: $80 → $87
Current: $13.16
Upside: +561.09%
Feb 27, 2025
Reiterates: Buy
Price Target: $27
Current: $14.38
Upside: +87.76%
Feb 27, 2025
Reiterates: Buy
Price Target: $425
Current: $284.25
Upside: +49.52%
Feb 27, 2025
Reiterates: Buy
Price Target: $7
Current: $0.98
Upside: +613.92%
Feb 26, 2025
Reiterates: Neutral
Price Target: $4
Current: $3.53
Upside: +13.31%
Feb 25, 2025
Reiterates: Buy
Price Target: $30
Current: $7.53
Upside: +298.41%
Feb 24, 2025
Reiterates: Buy
Price Target: $16
Current: $1.52
Upside: +952.63%
Feb 24, 2025
Reiterates: Buy
Price Target: $48
Current: $9.31
Upside: +415.85%
Feb 24, 2025
Reiterates: Buy
Price Target: $185
Current: $100.68
Upside: +83.75%
Feb 24, 2025
Reiterates: Buy
Price Target: $90
Current: $69.51
Upside: +29.48%
Feb 18, 2025
Reiterates: Buy
Price Target: $75
Current: $6.30
Upside: +1,090.48%
Feb 14, 2025
Reiterates: Buy
Price Target: $135
Current: $84.18
Upside: +60.37%
Feb 13, 2025
Maintains: Buy
Price Target: $300 → $241
Current: $116.49
Upside: +106.88%
Feb 11, 2025
Reiterates: Buy
Price Target: $550
Current: $477.52
Upside: +15.18%
Jan 13, 2025
Reiterates: Buy
Price Target: $75
Current: $20.41
Upside: +267.47%
Dec 20, 2024
Reiterates: Buy
Price Target: $80
Current: $23.10
Upside: +246.32%
Dec 17, 2024
Reiterates: Buy
Price Target: $30
Current: $1.68
Upside: +1,685.71%
Oct 24, 2024
Maintains: Buy
Price Target: $25 → $35
Current: $8.91
Upside: +292.82%
Aug 8, 2024
Reiterates: Buy
Price Target: $8
Current: $0.92
Upside: +769.47%
Nov 2, 2023
Maintains: Buy
Price Target: $17 → $7
Current: $1.40
Upside: +400.00%
Aug 15, 2023
Reiterates: Buy
Price Target: $10
Current: $6.16
Upside: +62.34%
Feb 13, 2023
Maintains: Buy
Price Target: $100 → $40
Current: $1.91
Upside: +1,994.24%
Jan 31, 2023
Reiterates: Buy
Price Target: $150
Current: $0.60
Upside: +25,110.08%
May 5, 2022
Downgrades: Neutral
Price Target: $200 → $60
Current: $9.55
Upside: +528.27%
Apr 27, 2022
Assumes: Buy
Price Target: $15
Current: $2.24
Upside: +569.64%
Mar 16, 2022
Maintains: Neutral
Price Target: $80 → $40
Current: $1.49
Upside: +2,584.56%